Cost-effectiveness of trifluridine/tipiracil against nivolumab for heavily pretreated metastatic gastric cancer in Japan

OBJECTIVE: Nivolumab and trifluridine/tipiracil have significantly improved the overall survival of patients with heavily pretreated metastatic gastric cancer in different placebo-controlled phase III trials. Accordingly, nivolumab and trifluridine/tipiracil have been approved and recommended for pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Takushima, Yusuke, Igarashi, Ataru, Yoshihara, Hiroshi, Shitara, Kohei, Doi, Toshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405843/
https://www.ncbi.nlm.nih.gov/pubmed/34128042
http://dx.doi.org/10.1093/jjco/hyab086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405843/
https://www.ncbi.nlm.nih.gov/pubmed/34128042
http://dx.doi.org/10.1093/jjco/hyab086

Ejemplares similares